home / stock / mycof / mycof news

MYCOF News and Press, New Age Brands From 01/07/21

Stock Information
Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com
Menu
MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCOF - Breaking News: Mydecine Innovations Group Shares Intellectual Property Update

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream us...
MYCOF - Mydecine Innovations Group Shares Intellectual Property Update

Company files seven provisional patent applications with United States Patent and Trademark Office DENVER, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharm...

MYCOF - Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

DENVER, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ...

MYCOF - Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

DENVER, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medic...
MYCOF - Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourc...

MYCOF - 4 Magic Mushroom Stocks You Might've Missed In December 2020

Psychedelic Stocks Are Taking A Bright Spotlight In December 2020 If you’re looking for magic mushroom stocks to buy , you’re likely to be hunting for penny stocks right now. The vast majority of these psychedelic names are under $5 right now. With the exception of...

MYCOF - Top Mushroom Penny Stocks To Watch For 2021

Are you Looking For Top Mushroom Stocks Right Now? Do you remember when marijuana penny stocks were all the rage? If you do then you’ve probably been trading for the last 6 years. Around 2014, we began seeing a new “fad” with traders buying marijuana stocks ...
MYCOF - Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics

The first Mydecine Speaker Series event will feature Mydecine Scientific Advisory Board Members Dr. Robin Carhart -Harris and Dr. Ruth Lanius , Chief Medical Officer Rakesh Jetly and Chief Scientific Officer Robert Roscow Moderated by ...

MYCOF - Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms

Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP nature-sourced psilocybin DENVER, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCO...

MYCOF - Mydecine Innovations Group to Restate Financial Statements

VANCOUVER, British Columbia, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO | OTC:MYCOF) announces that its previously issued financial statements for the fiscal year ended December 31, 2019, and the three- and six-month perio...
Previous 10 Next 10